Simon Cleary
@simoncleary.bsky.social
240 followers
300 following
15 posts
Research group leader and lecturer in pharmacology at King's College London: kcl.ac.uk/people/simon-cleary
Research interests: pulmonary vascular biology, immunology + developing new therapeutics and microscopy methods.
Posts
Media
Videos
Starter Packs
Reposted by Simon Cleary
Reposted by Simon Cleary
Reposted by Simon Cleary
Reposted by Simon Cleary
Reposted by Simon Cleary
Reposted by Simon Cleary
Beth Psaila
@bethpsaila.bsky.social
· Aug 15
Reposted by Simon Cleary
Reposted by Simon Cleary
Pedro Papotto
@ph-papotto.bsky.social
· Aug 4
Reposted by Simon Cleary
Simon Cleary
@simoncleary.bsky.social
· Jul 18
Reposted by Simon Cleary
SchurichLab
@schurichlab.bsky.social
· Jul 17
CAR-T cells containing CD28 versus 4-1BB co-stimulatory domains show distinct metabolic profiles in patients
Cook et al. investigate the metabolic profile of DLBCL patient-derived CAR-T cells
ex vivo. Comparing Axi-cel (CD28-co-stimulated) and Tisa-cel (4-1BB-co-stimulated)
products, they find divergent meta...
www.cell.com
Reposted by Simon Cleary
Reposted by Simon Cleary
Richard Hewitt
@drrjhewitt.bsky.social
· May 28
Epithelial damage and ageing: the perfect storm
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease of lung parenchymal scarring that is triggered by repeated microinjury to a vulnerable alveolar epithelium. It is increasingly r...
thorax.bmj.com
Simon Cleary
@simoncleary.bsky.social
· Jun 27
Reposted by Simon Cleary
Reposted by Simon Cleary
Reposted by Simon Cleary
Dave Barry
@david-j-barry.bsky.social
· May 30
Reposted by Simon Cleary
Reposted by Simon Cleary